The HemOnc Pulse
What are the Controversies Surrounding MRD in Blood Cancers?
On this episode of "The HemOnc Pulse," Alan Skarbnik, MD, of Novant Health, and Manni Mohyuddin, MBBS, of the University of Utah, discuss the concept of measurable residual disease (MRD) in hematologi